{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T06:00:43Z","timestamp":1784959243860,"version":"3.55.0"},"reference-count":29,"publisher":"The Japan Society of Coloproctology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Anus Rectum Colon"],"published-print":{"date-parts":[[2026,7,25]]},"DOI":"10.23922\/jarc.2025-124","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T22:11:10Z","timestamp":1784931070000},"page":"375-383","source":"Crossref","is-referenced-by-count":0,"title":["Verification of the Storage Stability of Fecal Hemoglobin in Stool Sampling Bottle Using Improved Buffer - A Pilot Study -"],"prefix":"10.23922","volume":"10","author":[{"given":"Masakatsu","family":"Fukuzawa","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tokyo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakiko","family":"Naito","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tokyo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin","family":"Kono","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tokyo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Yamauchi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tokyo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Morise","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tokyo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Uchida","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tokyo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Kagawa","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tokyo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Muramatsu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tokyo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiori","family":"Enomoto","sequence":"additional","affiliation":[{"name":"Eiken Chemical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuka","family":"Takehara","sequence":"additional","affiliation":[{"name":"Eiken Chemical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norimitsu","family":"Hosaka","sequence":"additional","affiliation":[{"name":"Eiken Chemical Co., Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Itoi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Tokyo Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10009","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bray F, Laversanne M, Sung H et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024 May-Jun; 74 (3):229-63.","DOI":"10.3322\/caac.21834"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Mandel JS, Church TR, Ederer F, et al : Colorectal Cancer Mortality. Effectiveness of Biennial Screening for Fecal Occult Blood. J Natl Cancer Inst. 1999 Mar; 91 (5):434-7.","DOI":"10.1093\/jnci\/91.5.434"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Mandel JS, Church TR, Bond JH, et al : The Effect of Fecal Occult Blood Screening on the Incidence of Colorectal Cancer. N Engl J Med. 2000 Nov; 343 (22):1603-7.","DOI":"10.1056\/NEJM200011303432203"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Allison JE, Sakoda LC, Levin TR, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007 Oct; 99 (19):1462-70.","DOI":"10.1093\/jnci\/djm150"},{"key":"5","unstructured":"5. Australian Institute of Health and Welfare 2014. Analysis of bowel cancer outcomes for the National Bowel Cancer Screening Program. Cat. No. CAN 87. Canberra: AIHW."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000 Nov; 343 (22):1603-7.","DOI":"10.1056\/NEJM200011303432203"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Ventura L, Mantellini P, Grazzini G, et al. The impact of immunochemical faecal occult blood testing on colorectal cancer incidence. Dig Liver Dis. 2014 Jan; 46 (1):82-6.","DOI":"10.1016\/j.dld.2013.07.017"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol. 2008 Jun; 103 (6):1541-9.","DOI":"10.1111\/j.1572-0241.2008.01875.x"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Garborg K, Holme \u00d8, L\u00f8berg M, et al. Current status of screening for colorectal cancer. Ann Oncol. 2013 Aug; 24 (8):1963-72.","DOI":"10.1093\/annonc\/mdt157"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Cole SR, Tucker GR, Osborne JM, et al. Shift to earlier stage at diagnosis as a consequence of the National Bowel Cancer Screening Program. Med J Aust. 2013 Apr; 198 (6):327-30.","DOI":"10.5694\/mja12.11357"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Zauber AG. The Impact of Screening on Colorectal Cancer Mortality and Incidence: Has It Really Made a Difference? Dig Dis Sci. 2015 Mar; 60 (3):681-91.","DOI":"10.1007\/s10620-015-3600-5"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Levi Z, Rozen P, Hazazi R, et al. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Intern Med. 2007 Feb; 146 (4):244-55.","DOI":"10.7326\/0003-4819-146-4-200702200-00003"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Symonds EL, Cole SR, Bastin D, et al. Effect of sample storage temperature and buffer formulation on faecal immunochemical test haemoglobin measurements. J Med Screen. 2017 Dec; 24 (4):176-181.","DOI":"10.1177\/0969141316686808"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Blake SN, Kortlever TL, Verbrugge SE, et al. Stable hemoglobin concentration with fecal immunochemical test at high temperatures in a Caribbean colorectal cancer screening program. Clin Chim Acta. 2024 Jun; 560:119723.","DOI":"10.1016\/j.cca.2024.119723"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Osborne JM, Flight I, Wilson CJ, et al. The impact of sample type and procedural attributes on relative acceptability of different colorectal cancer screening regimens. Patient Prefer Adherence. 2018 Sep; 12:1825-36.","DOI":"10.2147\/PPA.S172143"},{"key":"16","unstructured":"16. Chika U, Toshinari M, et al. [High Risk Group for Colorectal Cancer Detected Using the Immunological Test for Occult Blood in Feces]. J Gastrointestinal Cancer Screen. 2003; 31 (6):588-97. Japanese."},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Cardoso R, Guo F, Heisser T, et al. Utilisation of Colorectal Cancer Screening Tests in European Countries by Type of Screening Offer: Results from the European Health Interview Survey. Cancers (Basel). 2020 May; 12 (6):1409.","DOI":"10.3390\/cancers12061409"},{"key":"18","unstructured":"18. Centers for Disease Control and Prevention[Internet]. Mailed FIT Implementation Guide. [cited 2025 Aug 31]. Available from: https:\/\/www.cdc.gov\/colorectal-cancer\/php\/mailed-fit\/"},{"key":"19","unstructured":"19. Ministry of Health, Labour and Welfare. Guidelines for Cancer Prevention Health Education and Cancer Screening (Health Service Bureau Notification No. 0331058, March 31, 2008, with subsequent partial revision on June 23, 2023)"},{"key":"20","unstructured":"20. The Japanese Society of Gastrointestinal Cancer Screening. [A Handbook of Colorectal Cancer Screening 2021]. J Jpn Soc Gastrointest Cancer Screen. 2022 May; 60 (3):431-4. Japanese."},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Jager M, Demb J, Asghar A, et al. Mailed Outreach Is Superior to Usual Care Alone for Colorectal Cancer Screening in the USA: A Systematic Review and Meta-analysis. Dig Dis Sci. 2019 Sep; 64 (9):2489-96.","DOI":"10.1007\/s10620-019-05587-6"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Symonds EL, Cole SR, Bastin D, et al. Effect of sample storage temperature and buffer formulation on faecal immunochemical test haemoglobin measurements. J Med Screen. 2017 Dec; 24 (4):176-81.","DOI":"10.1177\/0969141316686808"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Symonds EL, Osborne JM, Cole SR, et al. Factors affecting faecal immunochemical test positive rates: demographic, pathological, behavioural and environmental variables. J Med Screen. 2015 Dec; 22 (4):187-93.","DOI":"10.1177\/0969141315584783"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Dancourt V, Hamza S, Manfredi S et al. Influence of sample return time and ambient temperature on the performance of an immunochemical faecal occult blood test with a new buffer for colorectal cancer screening. Eur J Cancer Prev. 2016 Mar; 25 (2) :109-14.","DOI":"10.1097\/CEJ.0000000000000153"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. van Roon AH, Hol L, van Vuuren AJ, et al. Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial. Am J Gastroenterol. 2012 Jan; 107 (1):99-107.","DOI":"10.1038\/ajg.2011.396"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Vilkin A, Rozen P, Levi Z, et al. Performance characteristics and evaluation of an automated-developed and quantitative, immunochemical, fecal occult blood screening test. Am J Gastroenterol. 2005 Nov; 100 (11):2519-25.","DOI":"10.1111\/j.1572-0241.2005.00231.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Guittet L, Guillaume E, Levillain R, et al. Analytical comparison of three quantitative immunochemical fecal occult blood tests for colorectal cancer screening. Cancer Epidemiol Biomarkers Prev. 2011 Jul; 20 (7):1492-501.","DOI":"10.1158\/1055-9965.EPI-10-0594"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Lasson A, Stotzer PO, \u00d6hman L, et al. The intra-individual variability of faecal calprotectin: a prospective study in patients with active ulcerative colitis. J Crohns Colitis. 2015 Jan; 9 (1):26-32.","DOI":"10.1016\/j.crohns.2014.06.002"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hamer HM, Mulder AH, de Boer NK, et al. Impact of Preanalytical Factors on Calprotectin Concentration in Stool: A Multiassay Comparison. J Appl Lab Med. 2022 Oct; 7 (6):1401-11.2","DOI":"10.1093\/jalm\/jfac057"}],"container-title":["Journal of the Anus, Rectum and Colon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/10\/3\/10_2025-124\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:11:06Z","timestamp":1784956266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jarc\/10\/3\/10_2025-124\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,25]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.23922\/jarc.2025-124","relation":{},"ISSN":["2432-3853"],"issn-type":[{"value":"2432-3853","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,25]]},"article-number":"2025-124"}}